Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M57.6Revenue (TTM) $M20.1Net Margin (%)-58.9Altman Z-Score-20.8
Enterprise Value $M43.4EPS (TTM) $-0.2Operating Margin %-47.3Piotroski F-Score3
P/E(ttm)--Beneish M-Score2.3Pre-tax Margin (%)-58.4Higher ROA y-yY
Price/Book5.810-y EBITDA Growth Rate %--Quick Ratio2.8Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-77.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M58.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVEOSeth Klarman 2014-12-31 Sold Out -0.07%$0.65 - $1.17
($0.91)
$ 0.999%Sold Out0
AVEOGeorge Soros 2014-09-30 Sold Out $1.09 - $1.79
($1.26)
$ 0.99-21%Sold Out0
AVEOGeorge Soros 2014-06-30 Buy $1.02 - $1.72
($1.29)
$ 0.99-23%New holding49,076
AVEOSeth Klarman 2013-06-30 Reduce-0.26%$2.34 - $8.27
($4.27)
$ 0.99-77%Reduce -21.90%3,829,350
AVEOGeorge Soros 2011-12-31 Sold Out -0.0031%$14.53 - $17.35
($8.42)
$ 0.99-88%Sold Out0
AVEOSeth Klarman 2011-09-30 Add0.29%$15.12 - $20.77
($17.66)
$ 0.99-94%Add 12.79%5,000,000
AVEOGeorge Soros 2011-09-30 Reduce-0.04%$15.12 - $20.77
($17.66)
$ 0.99-94%Reduce -92.80%11,600
AVEOSeth Klarman 2011-06-30 Add0.78%$13.06 - $20.66
($16.79)
$ 0.99-94%Add 25.76%4,433,010
AVEOGeorge Soros 2011-06-30 Buy 0.05%$13.06 - $20.66
($16.79)
$ 0.99-94%New holding161,000
AVEOSeth Klarman 2011-03-31 Add1.15%$13.15 - $15.02
($14.21)
$ 0.99-93%Add 76.25%3,525,000
AVEOSeth Klarman 2010-12-31 Buy 1.68%$13.84 - $17.41
($15.14)
$ 0.99-93%New holding2,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVEO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dallas Matthew DVP, Finance 2015-01-16Sell3,075$0.8220.73view
Gyuris JenoSVP, Chief Scientific Officer 2015-01-07Sell4,484$0.823.75view
Vittiglio JosephSVP, General Counsel 2015-01-07Sell4,484$0.823.75view
Dallas Matthew DVP, Finance 2015-01-07Sell519$0.823.75view
BAILEY MICHAEL PPresident & CEO 2015-01-07Sell4,484$0.823.75view
Dallas Matthew DVP, Finance 2014-07-01Sell0$023.75view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-39.63view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-39.63view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-39.63view
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-39.63view

Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
    Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
    Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
    Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
    Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
    AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
    Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
    Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

    More From Other Websites
    AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4% Jul 22 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : July 19, 2016 Jul 19 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : July 6, 2016 Jul 06 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement,... Jun 15 2016
    AVEO to Present at the 2016 JMP Securities Life Science Conference Jun 15 2016
    AVEO to Present at the 2016 JMP Securities Life Science Conference Jun 15 2016
    Will AVEO Pharmaceuticals (AVEO) Continue to Surge Higher? Jun 08 2016
    ETF’s with exposure to AVEO Pharmaceuticals, Inc. : June 3, 2016 Jun 03 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 31 2016
    AVEO Pharmaceuticals, Inc. :AVEO-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 May 26 2016
    AVEO Announces Dosing of First Patient in the Pivotal Phase 3 TIVO-3 Study of Tivozanib in Renal... May 26 2016
    AVEO Announces Dosing of First Patient in the Pivotal Phase 3 TIVO-3 Study of Tivozanib in Renal... May 26 2016
    AVEO PHARMACEUTICALS INC Financials May 19 2016
    Coverage initiated on AVEO Oncology by Piper Jaffray May 19 2016
    AVEO Announces Closing of Private Placement and Amended Term Loan to Fund Pivotal TIVO-3 Trial and... May 18 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an... May 18 2016
    AVEO Announces Closing of Private Placement and Amended Term Loan to Fund Pivotal TIVO-3 Trial and... May 18 2016
    AVEO Announces $17 Million Private Placement May 13 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... May 13 2016
    AVEO Announces $17 Million Private Placement May 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)